Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.840
+0.340 (7.56%)
At close: Jun 22, 2026, 4:00 PM EDT
4.866
+0.026 (0.54%)
After-hours: Jun 22, 2026, 7:54 PM EDT
Aclaris Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Initiates $13 | Buy | Initiates | $13 | +168.60% | Jun 1, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 | Buy | Maintains | $11 | +127.27% | May 11, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $12 | Buy | Reiterates | $12 | +147.93% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $16 | Buy | Reiterates | $16 | +230.58% | May 11, 2026 |
| Wedbush | Wedbush | Buy Maintains $10 | Buy | Maintains | $10 | +106.61% | May 8, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $10 | Buy | Reiterates | $10 | +106.61% | May 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $4 | Hold | Maintains | $4 | -17.36% | May 8, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $10 | Buy | Maintains | $10 | +106.61% | May 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.